BOLD: Boundless Bio Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Boundless Bio Inc (BOLD).
$64.67M Market Cap.
BOLD Market Cap. (MRY)
BOLD Shares Outstanding (MRY)
BOLD Assets (MRY)
Total Assets
$206.41M
Total Liabilities
$55.77M
Total Investments
$125.53M
BOLD Income (MRY)
Revenue
$0
Net Income
-$65.36M
Operating Expense
$73.27M
BOLD Cash Flow (MRY)
CF Operations
-$60.84M
CF Investing
-$26.10M
CF Financing
$89.82M
BOLD Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Total Assets | $206,409,000 (58.91%) | $129,894,000 (69.07%) | $76,829,000 |
Assets Current | $154,390,000 (24.30%) | $124,204,000 (82.55%) | $68,037,000 |
Assets Non-Current | $52,019,000 (814.22%) | $5,690,000 (-35.28%) | $8,792,000 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | $150,642,000 (218.54%) | -$127,082,000 (-55.55%) | -$81,696,000 |
Property Plant & Equipment Net | $51,360,000 (1022.62%) | $4,575,000 (-40.78%) | $7,726,000 |
Cash & Equivalents | $27,147,000 (11.87%) | $24,266,000 (111.30%) | $11,484,000 |
Accumulated Other Comprehensive Income | $121,000 (202.50%) | $40,000 (110.05%) | -$398,000 |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 |
Total Investments | $125,527,000 (29.35%) | $97,046,000 (74.02%) | $55,766,000 |
Investments Current | $125,527,000 (29.35%) | $97,046,000 (74.02%) | $55,766,000 |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 |
Inventory | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $5,354,000 (25.50%) | $4,266,000 (50.32%) | $2,838,000 |
Accumulated Retained Earnings (Deficit) | -$201,472,000 (-48.02%) | -$136,109,000 (-57.03%) | -$86,675,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 |
Total Debt | $47,632,000 (2070.02%) | $2,195,000 (-57.65%) | $5,183,000 |
Debt Current | $0 (0%) | $2,195,000 (-6.12%) | $2,338,000 |
Debt Non-Current | $47,632,000 (0%) | $0 (0%) | $2,845,000 |
Total Liabilities | $55,767,000 (495.86%) | $9,359,000 (-11.53%) | $10,579,000 |
Liabilities Current | $8,135,000 (-13.08%) | $9,359,000 (21.11%) | $7,728,000 |
Liabilities Non-Current | $47,632,000 (0%) | $0 (0%) | $2,851,000 |
BOLD Income Statement (MRY)
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $18,000,000 (48.04%) | $12,159,000 (30.60%) | $9,310,000 |
Research & Development Expense | $55,267,000 (29.62%) | $42,637,000 (14.74%) | $37,159,000 |
Operating Expenses | $73,267,000 (33.71%) | $54,796,000 (17.92%) | $46,469,000 |
Interest Expense | $0 (0%) | $0 (0%) | $0 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$65,363,000 (-32.22%) | -$49,434,000 (-7.70%) | -$45,901,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 |
Net Income | -$65,363,000 (-32.22%) | -$49,434,000 (-7.70%) | -$45,901,000 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$65,363,000 (-32.22%) | -$49,434,000 (-7.70%) | -$45,901,000 |
Weighted Average Shares | $16,984,000 (1296.71%) | $1,216,000 (10.75%) | $1,098,000 |
Weighted Average Shares Diluted | $16,984,000 (1296.71%) | $1,216,000 (10.75%) | $1,098,000 |
Earning Before Interest & Taxes (EBIT) | -$65,363,000 (-32.22%) | -$49,434,000 (-7.70%) | -$45,901,000 |
Gross Profit | $0 (0%) | $0 (0%) | $0 |
Operating Income | -$73,267,000 (-33.71%) | -$54,796,000 (-17.92%) | -$46,469,000 |
BOLD Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Net Cash Flow from Investing | -$26,101,000 (31.78%) | -$38,260,000 (-337.17%) | $16,132,000 |
Net Cash Flow from Financing | $89,823,000 (-8.25%) | $97,897,000 (77596.03%) | $126,000 |
Net Cash Flow from Operations | -$60,841,000 (-29.85%) | -$46,855,000 (-18.33%) | -$39,596,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | $2,881,000 (-77.46%) | $12,782,000 (154.77%) | -$23,338,000 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | -$23,565,000 (37.37%) | -$37,627,000 (-318.79%) | $17,198,000 |
Capital Expenditure | -$2,536,000 (-300.63%) | -$633,000 (40.62%) | -$1,066,000 |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 |
Issuance (Purchase) of Equity Shares | $89,823,000 (5163.30%) | -$1,774,000 (-1507.94%) | $126,000 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $7,516,000 (125.30%) | $3,336,000 (45.68%) | $2,290,000 |
Depreciation Amortization & Accretion | $3,637,000 (9.65%) | $3,317,000 (30.13%) | $2,549,000 |
BOLD Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Gross Margin | - | - | - |
Profit Margin | - | - | - |
EBITDA Margin | - | - | - |
Return on Average Equity (ROAE) | -73.90% (-255.91%) | 47.40% | - |
Return on Average Assets (ROAA) | -38.10% (20.29%) | -47.80% | - |
Return on Sales (ROS) | - | - | - |
Return on Invested Capital (ROIC) | -45.60% (25.61%) | -61.30% | - |
Dividend Yield | 0% | - | - |
Price to Earnings Ratio (P/E) | -0.75 | - | - |
Price to Sales Ratio (P/S) | - | - | - |
Price to Book Ratio (P/B) | 0.43 | - | - |
Debt to Equity Ratio (D/E) | 0.37 (600.00%) | -0.07 (42.64%) | -0.13 |
Earnings Per Share (EPS) | -3.85 (90.53%) | -40.65 (2.75%) | -41.8 |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 |
Free Cash Flow Per Share (FCFPS) | -3.73 (90.44%) | -39.05 (-5.45%) | -37.03 |
Book Value Per Share (BVPS) | 8.87 (108.49%) | -104.51 (-40.46%) | -74.4 |
Tangible Assets Book Value Per Share (TABVPS) | 12.15 (-88.62%) | 106.82 (52.66%) | 69.97 |
Enterprise Value Over EBIT (EV/EBIT) | 0 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.39 | - | - |
Asset Turnover | 0 (0%) | 0 | - |
Current Ratio | 18.98 (43.00%) | 13.27 (50.74%) | 8.8 |
Dividends | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$63,377,000 (-33.46%) | -$47,488,000 (-16.79%) | -$40,662,000 |
Enterprise Value (EV) | $24,017,125 | - | - |
Earnings Before Tax (EBT) | -$65,363,000 (-32.22%) | -$49,434,000 (-7.70%) | -$45,901,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$61,726,000 (-33.85%) | -$46,117,000 (-6.38%) | -$43,352,000 |
Invested Capital | $218,759,000 (122.17%) | $98,464,000 (56.79%) | $62,800,000 |
Working Capital | $146,255,000 (27.35%) | $114,845,000 (90.43%) | $60,309,000 |
Tangible Asset Value | $206,409,000 (58.91%) | $129,894,000 (69.07%) | $76,829,000 |
Market Capitalization | $64,670,125 | - | - |
Average Equity | $88,446,750 (184.73%) | -$104,389,000 | - |
Average Assets | $171,695,500 (66.11%) | $103,361,500 | - |
Invested Capital Average | $143,400,500 (77.85%) | $80,632,000 | - |
Shares | 22,300,043 (39.47%) | 15,989,333 | - |